rs1555907463
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_203446.3(SYNJ1):c.395G>A(p.Trp132*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_203446.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 53Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- early-onset Parkinson disease 20Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- atypical juvenile parkinsonismInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- young-onset Parkinson diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_203446.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SYNJ1 | NM_203446.3 | MANE Select | c.395G>A | p.Trp132* | stop_gained | Exon 4 of 33 | NP_982271.3 | ||
| SYNJ1 | NM_003895.4 | c.512G>A | p.Trp171* | stop_gained | Exon 4 of 32 | NP_003886.3 | |||
| SYNJ1 | NM_001160306.2 | c.395G>A | p.Trp132* | stop_gained | Exon 4 of 28 | NP_001153778.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SYNJ1 | ENST00000674351.1 | MANE Select | c.395G>A | p.Trp132* | stop_gained | Exon 4 of 33 | ENSP00000501530.1 | ||
| SYNJ1 | ENST00000433931.7 | TSL:1 | c.512G>A | p.Trp171* | stop_gained | Exon 4 of 32 | ENSP00000409667.2 | ||
| SYNJ1 | ENST00000630077.3 | TSL:1 | c.395G>A | p.Trp132* | stop_gained | Exon 4 of 28 | ENSP00000487560.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Early-onset Parkinson disease 20 Pathogenic:1
This variant was found in two German patients with epilepsy early in the disease course, followed by progressive generalized dopa-responsive dystonia associated with severe action tremor of the tongue, head, and extremities in their early teen years, and cognitive deterioration. We identified compound heterozygous mutations (NP_982271.2:p.Trp171*/NP_982271.2:p.Arg258Gln) in the SYNJ1 gene, affecting the N-terminal suppressor of actin1 (SAC1)-like domain of the SYNJ1 protein.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at